Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribulose-5-phosphate-3-epimerase pseudogene 4 (RPEP4) is a genomic region with sequence similarity to the ribulose-5-phosphate-3-epimerase (RPE) gene, which encodes an enzyme involved in the pentose phosphate pathway and the Calvin cycle[2][6][4][8]. RPEP4, however, is classified as a pseudogene, meaning it is not translated into a functional protein[7][5]. Pseudogenes were historically regarded as nonfunctional "junk" DNA, but some are known to possess regulatory roles such as competitive endogenous RNA in certain cellular contexts[5]. Currently, there is no scientific evidence supporting a functional role, disease association, or drug target status for RPEP4 specifically. It should not be mistaken for the functional enzyme RPE (ribulose-5-phosphate 3-epimerase), which participates in key cellular metabolic pathways[2][6][8][4]. If you require information on the functional enzyme or its gene, refer instead to "ribulose-5-phosphate 3-epimerase" (RPE), which is an enzyme with metabolic and potential disease relevance[2][6][8][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribulose-5-phosphate-3-epimerase pseudogene 4 (RPEP4).